JP2023121755A5 - - Google Patents

Download PDF

Info

Publication number
JP2023121755A5
JP2023121755A5 JP2023093879A JP2023093879A JP2023121755A5 JP 2023121755 A5 JP2023121755 A5 JP 2023121755A5 JP 2023093879 A JP2023093879 A JP 2023093879A JP 2023093879 A JP2023093879 A JP 2023093879A JP 2023121755 A5 JP2023121755 A5 JP 2023121755A5
Authority
JP
Japan
Prior art keywords
sequence
seq
nucleic acid
bacterial strain
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023093879A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023121755A (ja
Filing date
Publication date
Priority claimed from PCT/US2018/060187 external-priority patent/WO2019094837A1/en
Application filed filed Critical
Publication of JP2023121755A publication Critical patent/JP2023121755A/ja
Publication of JP2023121755A5 publication Critical patent/JP2023121755A5/ja
Priority to JP2025105253A priority Critical patent/JP2025170783A/ja
Pending legal-status Critical Current

Links

JP2023093879A 2017-11-09 2023-06-07 アレルギーの処置のための組成物および方法 Pending JP2023121755A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025105253A JP2025170783A (ja) 2017-11-09 2025-06-23 アレルギーの処置のための組成物および方法

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201762583777P 2017-11-09 2017-11-09
US62/583,777 2017-11-09
US201862637355P 2018-03-01 2018-03-01
US62/637,355 2018-03-01
US201862721786P 2018-08-23 2018-08-23
US62/721,786 2018-08-23
PCT/US2018/060187 WO2019094837A1 (en) 2017-11-09 2018-11-09 Compositions and methods for the treatment of allergy
JP2020526142A JP7293220B2 (ja) 2017-11-09 2018-11-09 アレルギーの処置のための組成物および方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020526142A Division JP7293220B2 (ja) 2017-11-09 2018-11-09 アレルギーの処置のための組成物および方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025105253A Division JP2025170783A (ja) 2017-11-09 2025-06-23 アレルギーの処置のための組成物および方法

Publications (2)

Publication Number Publication Date
JP2023121755A JP2023121755A (ja) 2023-08-31
JP2023121755A5 true JP2023121755A5 (https=) 2023-11-15

Family

ID=66438676

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020526142A Active JP7293220B2 (ja) 2017-11-09 2018-11-09 アレルギーの処置のための組成物および方法
JP2023093879A Pending JP2023121755A (ja) 2017-11-09 2023-06-07 アレルギーの処置のための組成物および方法
JP2025105253A Pending JP2025170783A (ja) 2017-11-09 2025-06-23 アレルギーの処置のための組成物および方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020526142A Active JP7293220B2 (ja) 2017-11-09 2018-11-09 アレルギーの処置のための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025105253A Pending JP2025170783A (ja) 2017-11-09 2025-06-23 アレルギーの処置のための組成物および方法

Country Status (7)

Country Link
US (1) US12582679B2 (https=)
EP (1) EP3706767A4 (https=)
JP (3) JP7293220B2 (https=)
CN (1) CN111526882A (https=)
AU (1) AU2018365071B2 (https=)
CA (1) CA3081978A1 (https=)
WO (1) WO2019094837A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3706767A4 (en) 2017-11-09 2021-12-15 Vedanta Biosciences, Inc. COMPOSITIONS AND METHODS FOR THE TREATMENT OF AN ALLERGY
EP3723776A4 (en) 2017-12-11 2022-07-27 Vedanta Biosciences, Inc. Compositions and methods for suppressing pathogenic organisms
JP2022549133A (ja) * 2019-09-16 2022-11-24 ヴェダンタ バイオサイエンシーズ インコーポレーテッド 細菌を保存するための方法および組成物
CN117202919A (zh) 2021-02-18 2023-12-08 韦丹塔生物科学股份有限公司 用于抑制病原生物体的组合物和方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006284922B2 (en) * 2005-08-30 2012-01-19 University Of Miami Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists and immunotoxins
ES2993669T3 (en) * 2011-12-01 2025-01-03 Univ Tokyo Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
US8906668B2 (en) * 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
US9956282B2 (en) * 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
AU2015244700B2 (en) * 2014-04-10 2020-08-27 Riken Compositions and methods for induction of Th17 cells
CN115252650A (zh) * 2015-11-03 2022-11-01 布里格姆及妇女医院股份有限公司 用于治疗和/或预防食物变态反应的治疗性微生物群
WO2017160944A2 (en) * 2016-03-15 2017-09-21 The Regents Of The University Of Michigan Compositions and methods for treating and preventing graft versus host disease
US9999641B2 (en) * 2016-06-14 2018-06-19 Vedanta Biosciences, Inc. Treatment of clostridium difficile infection
CA3226196A1 (en) * 2016-06-14 2017-12-21 Vedanta Biosciences, Inc. Treatment of clostridium difficile infection
EP3606325B1 (en) * 2017-04-03 2024-09-04 Gusto Global, LLC Rational design of microbial-based biotherapeutics
EP3706767A4 (en) 2017-11-09 2021-12-15 Vedanta Biosciences, Inc. COMPOSITIONS AND METHODS FOR THE TREATMENT OF AN ALLERGY
US10507221B2 (en) 2017-11-09 2019-12-17 Vedanta Biosciences, Inc. Compositions and methods for the treatment of allergy
JP7846613B2 (ja) * 2019-08-09 2026-04-15 ヴェダンタ バイオサイエンシーズ インコーポレーテッド 病原菌を抑制するための組成物及び方法

Similar Documents

Publication Publication Date Title
JP2023121755A5 (https=)
US8557233B2 (en) Probiotic bifidobacterium strains
Matsuzaki et al. Modulating immune responses with probiotic bacteria
Oyetayo et al. Potential of probiotics as biotherapeutic agents targeting the innate immune system
EP2522358B1 (en) Peptides against rotavirus infection
KR101178217B1 (ko) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
US20140328879A1 (en) Probiotic bifidobacterium strains
CN1694954B (zh) 用于降低由螺杆菌引起炎症的乳酸菌的选择和应用
JP2005529960A5 (https=)
CN106795482B (zh) 允许在营养不良的情况下促进人和动物的幼年生长的乳杆菌组合物
CN114774315B (zh) 鼠李糖乳杆菌菌株LRa05在制备增强免疫力制品和/或缓解湿疹制品方面的用途
WO2020197188A1 (ko) 관절염 저감화 효능을 갖는 김치 유산균 락토바실러스 사케아이 wikim0109
Amrouche et al. Probiotics for immunomodulation in prevention against respiratory viral infections with special emphasis on COVID-19
WO2010001509A1 (ja) イムノグロブリンa誘導能の高い新規乳酸菌
JP6705628B2 (ja) 形質細胞様樹状細胞誘導剤
KR102822968B1 (ko) 락티카제이바실러스 람노서스 균주 및 이의 면역 증진 용도
JP2021502391A5 (https=)
JP5019961B2 (ja) インターロイキン10産生促進剤
AU2010228525B2 (en) Method for producing lactic acid bacteria having enhanced immunoregulating activities
JP4498924B2 (ja) ラクトバシラス・カゼイ亜種カゼイ増殖促進用組成物
JPH07228536A (ja) 乳酸菌を用いた免疫賦活剤
JPH05252900A (ja) 免疫賦活組成物
CN114806967B (zh) 一株高产肌苷具有抗炎作用的副干酪乳杆菌
JP2006111573A (ja) バチルス・サブチルス菌株の使用及びその使用に用いられる菌株を含む食品
CN116590200A (zh) 约氏乳杆菌及其在制备预防和/或改善急性胰腺炎的产品中的应用